Lucia Domville, MIA, IRC®
Advisory Board
Back to About

Lucia Domville, MIA, IRC®

Capital Markets, Investor Relations & Strategic Communications Board Advisor, HMD

Lucia Domville, MIA, IRC®, is a capital markets, investor relations, and strategic communications executive with nearly three decades of experience advising public and private company boards, CEOs, and CFOs through major corporate milestones, including IPOs, M&A transactions, shareholder activism, restructurings, and crisis situations. She is the Founder and CEO of LuRi Group, a New York-based strategic advisory firm that works with senior leadership teams to strengthen corporate positioning, investor engagement, and long-term credibility in the capital markets.

Throughout her career, Lucia has advised boards and executive teams through more than 25 IPOs and over $6 billion in M&A and capital-markets transactions. Most recently, as Executive Vice President of Financial Communications and Capital Markets at Weber Shandwick, she advised clients through 12 M&A transactions exceeding $4 billion. Previously, during a 24-year career with Citigate Dewe Rogerson and Grayling, she rose to Head of U.S., built and led the firm’s investor relations practice, oversaw U.S. operations, and supported expansion across Latin America.

Her experience spans financial services, banking, fintech, alternative investments, energy, technology, healthcare, and other industries. Lucia has worked closely with institutional investors, investment banks, legal counsel, NYSE and Nasdaq, and leading financial media. Earlier in her career, she served as a Latin American fixed-income strategist at Santander Investment Securities and as a financial correspondent covering international trade and global capital markets.

At HMD, Lucia serves as Capital Markets, Investor Relations & Strategic Communications Board Advisor, providing strategic guidance on HMD’s capital-markets positioning, investor relations, corporate narrative, fundraising communications, institutional-investor readiness, executive positioning, and communications surrounding future financings, strategic partnerships, and other significant corporate transactions.

Lucia holds a Master’s in International Affairs from Columbia University’s School of International and Public Affairs, with a concentration in International Economic Policy and Latin America, and completed finance coursework at Columbia Business School. She graduated magna cum laude and as class valedictorian from Universidad Iberoamericana in Mexico City. She has also completed Wharton’s Corporate Governance: Maximizing Effectiveness in the Boardroom program and holds the IRC® Investor Relations certification from NIRI. Fluent in English, Spanish, and Portuguese, Lucia brings a global and cross-border perspective to HMD’s growth and capital-markets strategy.

Other Team Members

Bakary Jatta, M.D.
Chair & Founder, HMD
Vanessa Nunes De Paiva, MBA, Ph.D.
Chief Physician Liaison, HMD
Tracy Lewis, M.A.Ed., B.S. Psych.
Chief Experience & Engagement Officer
Wes Scruggs, MBA
Commercial & Growth Officer, HMD
Minna Cross
HMD Data & Analytics Lead
Mandefro Ayano, M.D.
HMD Internal Medicine
Karthik Saravanan, BMBCh Bound, BA (Oxon)
Strategic Advisor For Medical AI & UK Programs, HMD
Tsion Yehualashet Wubshet, M.D.
HMD Regional Executive, East Africa
Chidinma Nwoha, MD, MPH
HMD Regional Executive, West Africa
Mohamed Benlamin, M.D.
HMD Internal Medicine
Fahmida Zahin, MBBS Candidate
HMD Ambassador, United Kingdom
Melody Olajide, MBBS Candidate
HMD Ambassador, West Africa
Praise Emmanuel, MD Candidate
HMD Ambassador, Southern Europe
Riya Dhindsa, MD Candidate
HMD Podcast Fellow
Howard Maibach, M.D., FAAD
Advisory Board Member, HMD
Alexander D. Crosett III
Board Director, HMD
Nancy DiGioacchino, MBA, CPHQ, CPCO, HACP, CIPM
Healthcare Governance, Risk & Compliance Board Advisor, HMD
Kendra Mitchell, JD
Independent Director & Strategic Counsel, HMD
Angelika Korelc
Operations & Transformation Board Advisor, HMD
Mina Ghorbanifarajzadeh, DMD
Board Advisor for Clinical AI Implementation & Validation, HMD
Parul Nanda
Technical Board Advisor & Technology Lead
Joe Sedlak, MBA, RN, BSN
Healthcare Technology, Commercial Growth & Enterprise Strategy Board Advisor
Shelley Wisnowski, MHA, PT
Partnerships & Commercial Growth Board Advisor, HMD
Dan Gonzalez, PharmD
Clinical AI, Pharmacy & Digital Health Strategy Board Advisor, HMD
Melania Calinescu, PhD
AI & Data Strategy Board Advisor, HMD
Bryn Dunn
Finance, Capital & Corporate Strategy Advisor, HMD
Dr. Pierre Redelinghuys
HMD Senior Scientist & Strategic Board Advisor
Rachel Salazar, DHSc
Life Sciences, Clinical Innovation & Strategy Board Advisor, HMD